Estrogen and progesterone receptors in malignant mixed mesodermal tumors of the ovary
Authors:
- John P. GeislerJGJohn P. Geisler
- Greg A. MillerGMGreg A. Miller
- Zhen ZhouZZZhen Zhou
- 1 May 1995
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 59 (1) , 45-47
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Complete response of carcinosarcoma of the ovary to therapy with doxorubicin, ifosfamide, and dacarbazineGynecologic Oncology, 1991
- Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapyGynecologic Oncology, 1990
- Clinical correlation of hormone receptor status in epithelial ovarian cancerGynecologic Oncology, 1989
- Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomasGynecologic Oncology, 1989
- Adriamycin Chemotherapy for Malignant Mixed Mesodermal Tumor of the Ovary A Gynecologic Oncology Group StudyAmerican Journal of Clinical Oncology, 1986
- Five-year survival following combination radiotherapy and chemotherapy for recurrent mixed mesodermal sarcoma of the ovaryGynecologic Oncology, 1985
- A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: A gynecologic oncology group studyGynecologic Oncology, 1984
- Mixed mesodermal sarcoma of the ovary. Treatment with combination radiation therapy and chemotherapyCancer, 1983
- Mixed mesodermal tumor and clear cell carcinoma arising in ovarian endometriosisCancer, 1978
- Carcinosarcomas and mixed mesodermal tumors of the ovaryCancer, 1971